TX-HEWLETT-PACKARD
18.5.2021 13:02:29 CEST | Business Wire | Press release
Hewlett Packard Enterprise (NYSE: HPE) today announced solutions to help organizations advance data monetization by tapping into Gaia-X , an emerging federated data infrastructure supported by more than 300 organizations in Europe and globally.
The HPE Solution Framework for Gaia-X was designed for companies, service providers and public organizations that want to get ready to participate in Gaia-X. It supports virtually all capabilities that are required to both provide and consume data and services in a decentralized, federated environment. As a result, organizations can advance their ability to create value from data, tap into huge distributed data pools, and strengthen their sovereignty over their data-driven business model.
The framework is based on a reference architecture, leveraging key components of HPE’s software portfolio, third-party software, and the Cloud28+ business platform, a marketplace for the monetization of data and services. Individual solution components and entire solution environments are available as a service via HPE GreenLake cloud services.
HPE also announced the HPE Roadmap Service for Gaia-X which helps customers assess their Gaia-X readiness and develop a roadmap.
“Gaia-X is an answer to the key question of the next wave of digital transformation: How can we create network effects without centralizing all the data? This is perfectly in line with our company strategy which is focused on unlocking the value of data distributed across locations and clouds,” says Johannes Koch, Senior Vice President, Germany, Austria and Switzerland, HPE. “However, Gaia-X does not do the job alone. It requires a range of capabilities to benefit from this platform. In essence, you must know how to monetize data and put it to work. That’s exactly what we help customers achieve with our Gaia-X solutions.”
New era of decentralized data to drive economic and social progress
The European Commission has declared data value creation to be the crucial source of economic and social progress in the next decades. This will be driven by a “new wave” of industrial and professional data, with 80 percent of the overall data volume to be processed in a decentralized manner by 2025.
According to the World Economic Forum , this enables organizations to create “value from data insights” in the form of new revenue streams, new business models, better customer experiences, and better decisions. As an example, McKinsey estimates that the monetization of connected-car data could deliver $250 billion to $400 billion in annual incremental value for players across the mobility ecosystem in 2030. And the European Union’s data economy is forecasted to almost triple between 2018 and 2025 to reach a value of 829 billion Euros.
A radically new approach for sovereign data value creation
However, it’s not certain to which extent organizations will be able to actually materialize these opportunities. According to a global report by IDC and Seagate , only 32 percent of data available to enterprises are put to work. Moreover, according to the European Commission , “currently a small number of big tech firms hold a large part of the world’s data. This could reduce the incentives for data-driven businesses to emerge, grow and innovate.”
Decentralized cloud and data infrastructures take a radically new approach to address that challenge. They enable sharing and aggregation of data, insights, and services at scale without a central intermediary. This creates a level playing field, with power and opportunities distributed across all parties.
Gaia-X is emerging as a focal point of this endeavor. Gaia-X connects centralized and decentralized infrastructures to strengthen the ability to both access and share data securely and confidently. Gaia-X is now entering its operational phase with first flagship projects, and first Gaia-X-compliant solutions are expected to be certified in December 2021 .
HPE is supporting customers to get ready for Gaia-X
HPE is a day-1 member of the non-profit organization Gaia-X AISBL and contributes to the Gaia-X architecture, standards, and certification. HPE is already working with dozens of organizations across Europe to help them get ready for decentralized data infrastructures such as Gaia-X.
One of them is Orange Business Services , a European network-native digital services provider supporting customers worldwide to bring the best innovations with the strongest data protections. “We are helping shape the technical and dataspace foundations of the Gaia-X ecosystem, and we are currently adapting Orange Cloud services to these specifications in order to continue providing the most trusted cloud solutions to our customers within Gaia-X,” says Cedric Parent, Deputy CEO, Orange Cloud. “HPE is a key partner to power Orange Cloud platforms with state-of-the-art technology and capabilities. We benefit from HPE’s deep expertise and solution offering, which comprehensively support the developments needed to fully benefit from decentralized infrastructures such as Gaia-X.”
CSC - IT Center for Science Ltd , the Finnish organization hosting Europe‘s first pre-exascale supercomputer named LUMI , is currently preparing to make supercomputing available as part of an ecosystem of capabilities, where Gaia-X will play a major role. “We are working with HPE to provide trustworthy, secure and efficient supercomputing for research and industry. CSC is happy to provide its solid expertise in handling sensitive data, e.g. for the purposes of health research,” says Pekka Manninen, Director, LUMI Leadership Computing Facility, CSC.
Solution framework for Gaia-X readiness
A central element of the HPE Solution Framework for Gaia-X is a reference architecture that defines the foundation of the components necessary to build Gaia-X use cases. It ensures secure infrastructure operation for decentralized workloads and includes a central governance structure.
The technological foundation is the HPE Ezmeral Software Platform which provides capabilities such as unified access to distributed data and unified control of distributed Kubernetes clusters. HPE also leverages SPIFFE , the Secure Production Identity Framework For Everyone, and SPIRE , the SPIFFE Runtime Environment – open-source standards for securely authenticating software services through the use of platform-agnostic, cryptographic identities.
The Cloud28+ business platform enables customers to leverage and monetize their data and services via a marketplace. This platform was originally created as the service catalogue of the Cloud28+ community, and it’s now available to be used by individual organizations, in addition to HPE’s partner network.
An active contributor to the Gaia-X architecture and standards, HPE will equip its solution framework with the required interfaces, connectors and services so customers can seamlessly connect to the Gaia-X platform and ecosystem.
Availability
The HPE Solution Framework for Gaia-X and the HPE Roadmap Service for Gaia-X are available in Europe. Individual solution components and entire solution environments are available via HPE GreenLake cloud services. Gaia-X interfaces and connectors will be made available as soon as Gaia-X specifications are final.
About Hewlett Packard Enterprise
Hewlett Packard Enterprise is the global edge-to-cloud platform as-a-service company that helps organizations accelerate outcomes by unlocking value from all of their data, everywhere. Built on decades of reimagining the future and innovating to advance the way people live and work, HPE delivers unique, open and intelligent technology solutions, with a consistent experience across all clouds and edges, to help customers develop new business models, engage in new ways, and increase operational performance. For more information, visit: www.hpe.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20210518005050/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom